YDMI
ABBV icon

Y.D. More Investments’s AbbVie ABBV Stock Holding History

Y.D. More Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48.6K Sell
193
-383
-66% -$82.4K ﹤0.01% 322
2026
Q1 		$125K Sell
576
-449
-44% -$99.6K ﹤0.01% 236
2025
Q4 		$234K Sell
1,025
-205
-17% -$46.7K 0.01% 189
2025
Q3 		$285K Sell
1,230
-87
-7% -$17.7K 0.02% 177
2025
Q2 		$242K Sell
1,317
-91
-6% -$16.9K 0.02% 186
2025
Q1 		$295K Buy
1,408
+39
+3% +$7.58K 0.03% 178
2024
Q4 		$243K Buy
1,369
+198
+17% +$36.4K 0.02% 178
2024
Q3 		$231K Buy
1,171
+38
+3% +$7.09K 0.02% 181
2024
Q2 		$194K Buy
1,133
+763
+206% +$126K 0.02% 186
2024
Q1 		$67.4K Hold
370
– – 0.01% 223
2023
Q4 		$57.3K Hold
370
– – 0.01% 230
2023
Q3 		$55.2K Sell
370
-280
-43% -$41.1K 0.01% 231
2023
Q2 		$87.6K Sell
650
-141
-18% -$20.7K 0.02% 184
2023
Q1 		$126K Buy
791
+500
+172% +$76.4K 0.03% 163
2022
Q4 		$47.3K Buy
+291
New +$44.6K 0.01% 252

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Y.D. More Investments's ABBV Position: Q2 2026 in Review

Y.D. More Investments reduced its AbbVie (ABBV) stake by 66% in Q2 2026, selling an estimated $82.4K and leaving 193 shares worth $48.6K. The position accounts for ﹤0.01% of the portfolio, ranked #322.

Y.D. More Investments first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. The position peaked at $295K in Q1 2025. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Y.D. More Investments held 193 shares of AbbVie worth $48.6K as of Q2 2026.
  • Y.D. More Investments sold 383 AbbVie shares in Q2 2026, an estimated $82.4K.
  • AbbVie made up ﹤0.01% of Y.D. More Investments's portfolio in Q2 2026, its #322 holding.
  • Y.D. More Investments first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • Y.D. More Investments's AbbVie position peaked at $295K in Q1 2025.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Y.D. More Investments's 13F filing for Q2 2026, filed 5 Aug 2026.